Publication Name	World Journal of Clinical Cases
Manuscript ID	90377
Country	China

Received	2023-12-01 14:31
Peer-Review Started	2023-12-01 14:31
First Decision by Editorial Office Director	2023-12-07 02:51
Return for Revision	2023-12-07 02:51
Revised	2023-12-15 15:16
Publication Fee Transferred
Second Decision by Editor	2024-01-03 03:00
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director	2024-01-03 07:10
Articles in Press	2024-01-03 07:10
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-01-18 07:42
Publish the Manuscript Online	2024-01-25 08:28

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Translational Research
Article Title	Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer
Manuscript Source	Unsolicited Manuscript
All Author List	Zi-Zheng Wu, Yuan-Jun Wei, Tong Li, Jie Zheng, Yin-Feng Liu and Meng Han
ORCID	Author(s) ORCID Number Zi-Zheng Wu http://orcid.org/0000-0001-8253-0352 Meng Han http://orcid.org/0000-0003-1752-7442
Funding Agency and Grant Number
Corresponding Author	Meng Han, MD, Director, Director, Breast Disease Diagnosis and Treatment Center, The First Hospital of Qinhuangdao, No. 258 Wenhua Road, Haigang District, Qinhuangdao 066000, Hebei Province, China. menghan68527@163.com
Key Words	Breast cancer; Prognosis; Gene signature; The Cancer Genome Atlas; The Gene Expression Omnibus
Core Tip	Breast cancer (BC), a leading malignant disease, affects women all over the world. Cancer associated fibroblasts (CAFs) stimulate epithelial-mesenchymal transition, and induce chemoresistance and immunosuppression. We introduced a newly-discovered CAFs-associated gene signature using IL18, MYD88, GLIPR1, TNN, BHLHE41, DNAJB5, FKBP14, and XG, which can be employed to estimate BC patient outcomes conveniently and accurately.
Publish Date	2024-01-25 08:28
Citation	ZZ Wu, YJ Wei, Li T, Zheng J, Liu YF, Han M. Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer. World J Clin Cases 2024; 12(4): 700-720
URL	https://www.wjgnet.com/2307-8960/full/v12/i4/700.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i4.700

Full Article (PDF)	WJCC-12-700-with-cover.pdf
Full Article (Word)	WJCC-12-700.docx